Creoptix adds Robert Schier to its Board along with raising CHF8m Series C financing led by Swisscanto Invest
– SWITZERLAND, Wädenswil – Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced that is has raised CHF 8 million in the first closing as part of a Series C financing round led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation (NYSE: WAT) as well as existing private investors.…